South African guidelines for the management of nocturnal enuresis.
van Dyk
J C
JC
Duvenhage
F
F
Coetzee
L J E
LJ
Segone
A M
AM
Fockema
M
M
Smart
D
D
Haffejee
M
M
Lefakane
S B I
SB
Roos
J
J
Stellmacher
G
G
McGillevray
D
D
Bereczky
Z
Z
D000047:Academies and Institutes; D000929:Antidepressive Agents, Tricyclic; D002648:Child; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D000075202:Contraindications; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D004775:Enuresis / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D012076:Renal Agents / Q000627:therapeutic use; D020921:Sleep Arousal Disorders / Q000150:complications; D013019:South Africa; D001743:Urinary Bladder / Q000503:physiopathology; D014667:Vasopressins / Q000378:metabolism
D000929:Antidepressive Agents, Tricyclic; D018680:Cholinergic Antagonists; D012076:Renal Agents; D014667:Vasopressins; D003894:Deamino Arginine Vasopressin